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Why children do not receive treatment
Imti Choonara
Each year, worldwide, almost seven
million children under the age of ﬁve years
die.1 The majority of these children die
from diseases that are treatable (gastro-
enteritis, pneumonia and malaria are three
of the main causes). The main reason that
these children die is that neither they nor
their parents have access to healthcare.
The two main reasons why people do not
have access to healthcare are ﬁnancial
and geographical. Unfortunately, in many
countries, healthcare is considered a com-
modity rather than a right. Many parents,
therefore, cannot afford to purchase either
the treatment or even the consultation that
their child needs. This is highlighted in the
paper by Njuguna et al2 who describe how
parents of children with cancer in a single
centre in Kenya have to withdraw their
children from treatment because of inad-
equate ﬁnancial resources.
ACCESS TO HEALTHCARE
Healthcare is a basic human right. In 1948,
the United Nations released the Universal
Declaration of Human Rights. Article 25
stated: ‘Everyone has the right to a standard
of living adequate for the health and well-
being of himself and of his family, including
food, clothing, housing and medical care
and necessary social services, and the right
to security in the event of unemployment,
sickness, disability, widowhood, old age or
other lack of livelihood in circumstances
beyond his control’. The failure of govern-
ments to provide universal healthcare
results in the death of a signiﬁcant number
of children. This applies to high-income
countries as well as low-income countries.
The lack of universal healthcare is one of
the reasons for the higher under-ﬁve-year
mortality rate in the USA (8 per 1000 live
births) than in neighbouring Canada and
Cuba (6 per 1000 live births).1 Both
Canada and Cuba provide free universal
healthcare to their citizens.
Many of the poorest people live in rural
areas. These are less likely to have health
facilities, and where health facilities do exist,
parents may have to travel great distances
with their ill child in order to obtain a
medical opinion. UNICEF in its annual
report on the state of the world’s children
now records information regarding the per-
centage of children with diarrhoea who
receive oral rehydration salts, and the per-
centage who receive antibiotics for suspected
pneumonia.1 India has a booming economy
but a privatised healthcare system which fails
to meet the needs of its children. This is illu-
strated by the fact that only 26% of children
with diarrhoea receive treatment with oral
rehydration salts.1 The number of children
who received antibiotics for suspected pneu-
monia is only 13%.1 These ﬁgures are in
sharp contrast to neighbouring Bangladesh
which is signiﬁcantly poorer than India but
has ensured that 78% of children with
diarrhoea receive treatment with oral
rehydration salts, and 71% of children with
suspected pneumonia receive antibiotics.1
These ﬁgures help to explain why
Bangladesh has a lower under-ﬁve-year
mortality rate than India (46 vs 61, respect-
ively).1 Public services in Bangladesh have
focussed on reducing inequalities in access to
healthcare in the poorest sections of society.
ACCESS TO ESSENTIAL MEDICINES
It is ironic that India is one of the largest
manufacturers of pharmaceutical medi-
cines. Despite this, many of its citizens
cannot afford to purchase the medicines
that are required. Unfortunately, even if
parents can afford to buy medicines, the
medicines needed are often not available.
WHO has identiﬁed the essential medicines
that are needed for children. A study of 14
countries in central Africa highlighted that
many of these medicines were unavailable
in pharmacies.3 Governments and their
ministries of health need to ensure that
essential medicines are available in all areas,
and also that they are within the ﬁnancial
reach of the poorest members of society.
Pharmacies in isolated rural areas will have
a smaller stock of drugs then pharmacies in
large cities. It is important, therefore, to
have a coordinated system whereby the
larger pharmacies assist the smaller isolated
pharmacies to ensure that appropriate med-
icines are available to patients as they are
needed. This is not possible if every phar-
macy is competing with each other. Cuba
has shown that it is possible to establish a
system ensuring that people in isolated rural
communities have access to medicines.4
NEGLECTED DISEASES
Treatments are available for respiratory
infections, malaria and gastroenteritis, but
unfortunately, for many diseases that are
conﬁned to low-income countries medi-
cines have not been developed. WHO has
identiﬁed 17 tropical diseases for which
research into treatment has been neglected.
Neglected diseases include Chagas disease,
human African trypanosomiasis (sleeping
sickness), dengue, leprosy, rabies, leishman-
iasis, lymphatic ﬁlariasis and onchocerciasis
(river blindness). There are few medicines
available for these conditions, and often the
medicines available are highly toxic. This is
despite millions of people worldwide being
affected. Pharmaceutical companies exist to
make proﬁts, and proﬁts are more easily
generated for diseases that affect individuals
in high-income countries. It is important to
remember that the initial antimalarials were
only developed after World War II, when
soldiers from the USA or Europe developed
malaria. WHO needs to consider alterna-
tive ways of ensuring that funding is made
available for research into the development
of medicines for these diseases.
STIGMA
Children are dependent upon their parents
as well as health professionals for treatment.
Unfortunately, stigma associated with certain
medical conditions is associated with parents
choosing not to have treatment for their
children. This is illustrated by epilepsy
which affects over 10 million children
worldwide.5 In many countries, most chil-
dren do not receive treatment. It is estimated
that in the Lao People’s Democratic
Republic, 90% of children with epilepsy do
not receive treatment.5 Reasons for this
include the widespread belief that epilepsy is
a highly contagious disease. Large sections
of the population would not even share a
meal with someone with epilepsy.5 Many
health professionals had received no training
in epilepsy. One-third of doctors treating
children had never diagnosed epilepsy, and
one in four doctors working on a paediatric
ward thought that epilepsy was contagious.5
The provision of universal education
should help to reduce the effect of stigma.
Stigma, however, is not only a problem in
low-income countries. Mental health pro-
blems are one of the major causes of mor-
bidity in young people in the UK. Despite
this, there is considerable stigma attached to
mental illness, and many young people and
their families are reluctant to seek help.
Additionally, many paediatric health profes-
sionals have a dismissive attitude towards
mental health problems and consider them
less important than other conditions.
ADVOCACY
Worldwide, it is the poorest children and
their families who are usually deprived
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treatment. These individuals are the ones
with the least inﬂuence in society. Njuguna
and colleagues have provided these indivi-
duals with the opportunity of stating why
they have not been able to continue treat-
ment for their children. This is important,
and highlights the contribution that health
professionals can make to ensure that all
children have the right to receive treat-
ment. Health professionals and their orga-
nisations have a unique responsibility
in trying to ensure that children receive
treatment. Professional organisations,
worldwide, must be unremitting in their
pressure on governments to provide:
▸ universal healthcare
▸ universal education
▸ essential medicines that are available
and affordable.
These actions would have a major
impact on reducing child mortality and
morbidity throughout the world.
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